Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer-Reference-Cited by-同舟云学术

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer

Published:2015-10-22 Issue:12 Volume:106 Page:1750-1760
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Oguro Seiji¹²³⁴,Ino Yoshinori¹,Shimada Kazuaki³,Hatanaka Yutaka⁵⁶,Matsuno Yoshihiro⁵⁶,Esaki Minoru³,Nara Satoshi³,Kishi Yoji³,Kosuge Tomoo³⁴,Hiraoka Nobuyoshi¹²

Affiliation:

1. Division of Molecular Pathology National Cancer Center Research Institute Tokyo Japan

2. Division of Pathology and Clinical Laboratories National Cancer Center Hospital Tokyo Japan

3. Division of Hepatobiliary and Pancreatic Surgery Division National Cancer Center Hospital Tokyo Japan

4. Advanced Clinical Research of Cancer Juntendo University Graduate School of Medicine Tokyo Japan

5. Department of Surgical Pathology Hokkaido University Hospital Sapporo Japan

6. Research Division of Companion Diagnostics Hokkaido University Hospital Sapporo Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12825

Reference51 articles.

1. Diagnosis and Surgical Management of Gallbladder Cancer: A Review

2. Analysis of the Extent of Resection for Adenocarcinoma of the Gallbladder

3. Evolving Treatment Strategies for Gallbladder Cancer

4. Gallbladder cancer

5. A New Scoring System for Gallbladder Cancer (Aiding Treatment Algorithm): An Analysis of 335 Patients

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients;Frontiers in Immunology;2024-05-21

2. BTLA biology in cancer: from bench discoveries to clinical potentials;Biomarker Research;2024-01-17

3. BTLA and HVEM: Emerging players in the tumor microenvironment and cancer progression;Cytokine;2023-12

4. BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation – design, synthesis and biological evaluation;Biomedicine & Pharmacotherapy;2023-09

5. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy;Molecular Cancer;2023-08-30